2022 Competition Pharmacology 
Pharmaceutical Representative Training
JANUARY 8, 2025
Pharmacology is one of the most fundamental aspects of medication therapy. 1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? Due to limited knowledge of pharmacology, the sales rep failed to properly communicate and was unable to address the physicians concerns.
Map My Customers
MARCH 31, 2022
Not only is this field interesting and competitive, but it can also be lucrative. As a pharmaceutical sales rep, there are appointments and meetings with doctors and professionals that need to stay up to date with the latest pharmacology treatment options for their patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 4, 2023
It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US. The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008.
Impetus Digital
AUGUST 2, 2024
In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%. Market Analysis and Competitive Intelligence AI tools can analyze vast amounts of data from various sources to provide insights into market trends, competitor activities, and emerging opportunities.
European Pharmaceutical Review
JANUARY 31, 2025
By the end of the decade, two cell and gene therapies will be subject to follow-on competition for the first time, beginning a whole new chapter in the biosimilar history. 6 billion in 2024 alone). There has also been a multiplication of the nature of the biotechnology platforms involved. The path ahead should we change tack?
European Pharmaceutical Review
JULY 4, 2024
She also holds post-graduate diplomas from Oxford (IP Law) as well as King’s College (EU Competition Law). 2022 [cited 2024May]. She obtained a degree in physics from MIT prior to attending University of Pennsylvania Law School. National Institutes of Health (NIH) Available from: [link] Ahn K. researchspace.auckland.ac.nz.
MedCity News
JUNE 16, 2023
The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.
Expert insights. Personalized for you.
52 
Let's personalize your content